Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic cluster

Nature Communications

Volumn 5, Issue , 2014, Pages

  Valentino, Michael D ^a,b,c   McGuire, Abigail Manson ^c   Rosch, Jason W ^d   Bispo, Paulo J M ^a,b   Burnham, Corinna ^d   Sanfilippo, Christine M ^e,h   Carter, Robert A ^d   Zegans, Michael E ^f   Beall, Bernard ^g   Earl, Ashlee M ^c   Tuomanen, Elaine I ^d   Morris, Timothy W ^e,i   Haas, Wolfgang ^a,b   Gilmore, Michael S ^a,b,c  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e BAUSCH AND LOMB   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h UNIVERSITY OF ROCHESTER   (United States)

ⁱ Actelion Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; CHOLINE BINDING PROTEIN A; CHOLINE BINDING PROTEIN B; SIALIDASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIUM; GENOMICS; PATHOGENICITY; PHYLOGENETICS; RESPIRATORY DISEASE; VACCINE; VIRULENCE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONJUNCTIVITIS; GENE CLUSTER; GENETIC TRAIT; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; NONHUMAN; PHYLOGENETIC TREE; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ASYMPTOMATIC INFECTION; BACTERIAL CAPSULE; BACTERIAL GENOME; CONJUNCTIVITIS, BACTERIAL; GENETICS; HUMAN; MICROBIOLOGY; MULTIGENE FAMILY; PATHOGENICITY; PHYLOGENY; PHYLOGEOGRAPHY; PNEUMOCOCCAL INFECTIONS; WESTERN BLOTTING;

UNITED STATES;

STREPTOCOCCUS PNEUMONIAE;

ADHESINS, BACTERIAL; ASYMPTOMATIC INFECTIONS; BACTERIAL CAPSULES; BLOTTING, WESTERN; CONJUNCTIVITIS, BACTERIAL; GENOME, BACTERIAL; HUMANS; MULTIGENE FAMILY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PHYLOGEOGRAPHY; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VIRULENCE FACTORS;

EID: 84923239742     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6411     Document Type: Article

References (70)

1. Tuomanen, E. I., Austrian, R. & Masure, H. R. Pathogenesis of pneumococcal infection. N. Engl. J. Med. 332, 1280-1284 (1995).
2. Vernatter, J. & Pirofski, L. A. Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr. Opin. Infect. Dis. 26, 277-283 (2013).
3. Farrell, D. J., Klugman, K. P. & Pichichero, M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26, 123-128 (2007).
4. Buznach, N., Dagan, R. & Greenberg, D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr. Infect. Dis. J. 24, 823-828 (2005).
5. Karpecki, P. et al. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Clin. Ther. 31, 514-526 (2009).
6. McDonald, M. B. et al. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Ophthalmology 116, 1615-1623 (2009).
7. Tepedino, M. E. et al. Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. Curr. Med. Res. Opin. 25, 1159-1169 (2009).
8. Haas, W., Hesje, C. K., Sanfilippo, C. M. & Morris, T. W. High proportion of nontypeable Streptococcus pneumoniae isolates among sporadic, nonoutbreak cases of bacterial conjunctivitis. Curr. Eye Res. 36, 1078-1085 (2011).
9. Buck, J. M. et al. A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. Pediatr. Infect. Dis. J. 25, 906-911 (2006).
10. Martin, M. et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N. Engl. J. Med. 348, 1112-1121 (2003).
11. Shayegani, M., Parsons, L. M., Gibbons, Jr. W. E. & Campbell, D. Characterization of nontypable Streptococcus pneumoniae-like organisms isolated from outbreaks of conjunctivitis. J. Clin. Microbiol. 16, 8-14 (1982).
12. Centers for Disease Control and Prevention (CDC). Outbreak of bacterial conjunctivitis at a college - New Hampshire, January-March, 2002. Morb. Mortal. Wkly Rep. 51, 205-207 (2002).
13. Centers for Disease Control and Prevention (CDC). Pneumococcal conjunctivitis at an elementary school - Maine, September 20-December 6, 2002. Morb. Mortal. Wkly Rep. 52, 64-66 (2003).
14. Crum, N. F., Barrozo, C. P., Chapman, F. A., Ryan, M. A. & Russell, K. L. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin. Infect. Dis. 39, 1148-1154 (2004).
15. Hanage, W. P., Kaijalainen, T., Saukkoriipi, A., Rickcord, J. L. & Spratt, B. G. A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus. J. Clin. Microbiol. 44, 743-749 (2006).
16. Enright, M. C. & Spratt, B. G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144 (Pt 11), 3049-3060 (1998).
17. Zegans, M. E. et al. Clinical features, outcomes, and costs of a conjunctivitis outbreak caused by the ST448 strain of Streptococcus pneumoniae. Cornea 28, 503-509 (2009).
18. Marimon, J. M., Ercibengoa, M., Garcia-Arenzana, J. M., Alonso, M. &Perez-Trallero, E. Streptococcus pneumoniae ocular infections, prominent role of unencapsulated isolates in conjunctivitis. Clin. Microbiol. Infect. 19, E298-E305 (2013).
19. Croucher, N. J. et al. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat. Genet. 45, 656-663 (2013).
20. Marttinen, P. et al. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res. 40, e6 (2012).
21. Konstantinidis, K. T. & Tiedje, J. M. Genomic insights that advance the species definition for prokaryotes. Proc. Natl Acad. Sci. USA 102, 2567-2572 (2005).
22. Keller, L. E. et al. PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization. Infect. Immun. 81, 173-181 (2013).
23. Park, I. H. et al. Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK. MBio 3, pii: e00035-12 (2012).
24. Jakubovics, N. S., Stromberg, N., van Dolleweerd, C. J., Kelly, C. G. &Jenkinson, H. F. Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol. Microbiol. 55, 1591-1605 (2005).
25. Govindarajan, B. et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS ONE 7, e32418 (2012).
26. Menon, B. B. & Govindarajan, B. Identification of an atypical zinc metalloproteinase, ZmpC, from an epidemic conjunctivitis-causing strain of Streptococcus pneumoniae. Microb. Pathog. 56, 40-46 (2013).
27. Pettigrew, M. M., Fennie, K. P., York, M. P., Daniels, J. & Ghaffar, F. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect. Immun. 74, 3360-3365 (2006).
28. Gosink, K. K., Mann, E. R., Guglielmo, C., Tuomanen, E. I. & Masure, H. R. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect. Immun. 68, 5690-5695 (2000).
29. Bagnoli, F. et al. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J. Bacteriol. 190, 5480-5492 (2008).
30. Hilleringmann, M. et al. Molecular architecture of Streptococcus pneumoniae TIGR4 pili. EMBO J. 28, 3921-3930 (2009).
31. Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T. & van de Beek, D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin. Microbiol. Rev. 24, 557-591 (2011).
32. Luo, R. et al. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J. 24, 34-43 (2005).
33. Jerlstrom, P. G., Chhatwal, G. S. & Timmis, K. N. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol. Microbiol. 5, 843-849 (1991).
34. Mann, B. et al. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. J. Infect. Dis. 209, 1116-1125 (2014).
35. Zhang, J. R. et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102, 827-837 (2000).
36. Jerlstrom, P. G., Talay, S. R., Valentin-Weigand, P., Timmis, K. N. &Chhatwal, G. S. Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci. Infect. Immun. 64, 2787-2793 (1996).
37. Rosch, J. W., Mann, B., Thornton, J., Sublett, J. & Tuomanen, E. Convergence of regulatory networks on the pilus locus of Streptococcus pneumoniae. Infect. Immun. 76, 3187-3196 (2008).
38. Brown, J. S., Gilliland, S. M., Spratt, B. G. & Holden, D. W. A locus contained within a variable region of pneumococcal pathogenicity island 1 contributes to virulence in mice. Infect. Immun. 72, 1587-1593 (2004).
39. Frost, L. S., Leplae, R., Summers, A. O. & Toussaint, A. Mobile genetic elements: the agents of open source evolution. Nat. Rev. Microbiol. 3, 722-732 (2005).
40. Haas, W., Gearinger, L. S., Hesje, C. K., Sanfilippo, C. M. & Morris, T. W. Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin. Adv. Ther. 29, 442-455 (2012).
41. Chewapreecha, C. et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat. Genet. 46, 305-309 (2014).
42. Konstantinidis, K. T., Ramette, A. & Tiedje, J. M. The bacterial species definition in the genomic era. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361, 1929-1940 (2006).
43. Michel, J. L., Madoff, L. C., Kling, D. E., Kasper, D. L. & Ausubel, F. M. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect. Immun. 59, 2023-2028 (1991).
44. Kim, H. K., Thammavongsa, V., Schneewind, O. & Missiakas, D. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr. Opin. Microbiol. 15, 92-99 (2012).
45. Fagan, P. K., Reinscheid, D., Gottschalk, B. & Chhatwal, G. S. Identification and characterization of a novel secreted immunoglobulin binding protein from group A streptococcus. Infect. Immun. 69, 4851-4857 (2001).
46. Lofling, J., Vimberg, V., Battig, P. & Henriques-Normark, B. Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues. Cell. Microbiol. 13, 186-197 (2011).
47. Wells, P. A. & Hazlett, L. D. Complex carbohydrates at the ocular surface of the mouse: an ultrastructural and cytochemical analysis. Exp. Eye Res. 39, 19-35 (1984).
48. Hazlett, L. D., Moon, M. & Berk, R. S. In vivo identification of sialic acid as the ocular receptor for Pseudomonas aeruginosa. Infect. Immun. 51, 687-689 (1986).
49. Royle, L. et al. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj. J. 25, 763-773 (2008).
50. Donati, C. et al. Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol. 11, R107 (2010).
51. Brady, L. J. et al. The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol. Microbiol. 77, 276-286 (2010).
52. Jumblatt, M. M. et al. Glycoprotein 340 in normal human ocular surface tissues and tear film. Infect. Immun. 74, 4058-4063 (2006).
53. Carrolo, M., Frias, M. J., Pinto, F. R., Melo-Cristino, J. & Ramirez, M. Prophage spontaneous activation promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae. PLoS ONE 5, e15678 (2010).
54. Sachedina, S., Greiner, J. V. & Glonek, T. Phosphatic intermediate metabolites of the porcine ocular tunica fibrosa. Exp. Eye Res. 52, 253-260 (1991).
55. Pacheco, A. R. et al. Fucose sensing regulates bacterial intestinal colonization. Nature 492, 113-117 (2012).
56. Stahl, M. et al. L-fucose utilization provides Campylobacter jejuni with a competitive advantage. Proc. Natl Acad. Sci. USA 108, 7194-7199 (2011).
57. Isnard, N., Bourles-Dagonet, F., Robert, L. & Renard, G. Studies on corneal wound healing. Effect of fucose on iodine vapor-burnt rabbit corneas. Ophthalmologica 219, 324-333 (2005).
58. Croucher, N. J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
59. Lebreton, F. et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio 4, pii: e00534-13 (2013).
60. Weinert, L. A. et al. Molecular dating of human-to-bovid host jumps by Staphylococcus aureus reveals an association with the spread of domestication. Biol. Lett. 8, 829-832 (2012).
61. Maiden, M. C. et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl Acad. Sci. USA 95, 3140-3145 (1998).
62. Sanfilippo, C. M., Haas, W., Hesje, C. K. & Morris, T. W. in Association for Research in Vision and Ophthalmology (ARVO) (Fort Lauderdale, 2012).
63. Aziz, R. K. et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9, 75 (2008).
64. Delcher, A. L., Harmon, D., Kasif, S., White, O. & Salzberg, S. L. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27, 4636-4641 (1999).
65. Finn, R. D. et al. The Pfam protein families database. Nucleic Acids Res. 36, D281-D288 (2008).
66. Li, L., Stoeckert, Jr. C. J. & Roos, D. S. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 13, 2178-2189 (2003).
67. Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307-321 (2010).
68. Corander, J., Waldmann, P., Marttinen, P. & Sillanpaa, M. J. BAPS 2: enhanced possibilities for the analysis of genetic population structure. Bioinformatics 20, 2363-2369 (2004).
69. Zankari, E. et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67, 2640-2644 (2012).
70. Keller, L. E. et al. Draft genome sequences of five multilocus sequence types of nonencapsulated Streptococcus pneumoniae. Genome Announc 1, pii: e00520-13 (2013).